Y
Yong Chen
Researcher at Sun Yat-sen University
Publications - 56
Citations - 2872
Yong Chen is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Nasopharyngeal carcinoma & Nasopharyngeal neoplasm. The author has an hindex of 20, co-authored 45 publications receiving 2328 citations.
Papers
More filters
Journal ArticleDOI
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard,Pierre Blanchard,Anne W.M. Lee,Sophie Marguet,Julie Leclercq,Wai Tong Ng,Jun Ma,Anthony T.C. Chan,Pei Yu Huang,Ellen Benhamou,Ellen Benhamou,Guopei Zhu,Daniel T.T. Chua,Yong Chen,Hai-Qiang Mai,Dora L.W. Kwong,Shie Lee Cheah,James J. Moon,Yuk Tung,Kwan-Hwa Chi,George Fountzilas,Li Zhang,Edwin P. Hui,Taixiang Lu,Jean Bourhis,Jean Pierre Pignon,Jean Pierre Pignon +26 more
TL;DR: The results confirm that the addition of concomitant chemotherapy to radiotherapy significantly improves survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Journal ArticleDOI
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen,Chaosu Hu,Xiao Zhong Chen,Guoqing Hu,Zhi Bin Cheng,Yan Sun,Wei Xiong Li,Yuan Yuan Chen,Fang Yun Xie,Shao Bo Liang,Yong Chen,Ting Ting Xu,Bin Li,Guo Xian Long,Si Yang Wang,Bao Min Zheng,Ying Guo,Ying Sun,Yan Ping Mao,Ling Long Tang,Yu Ming Chen,Meng Zhong Liu,Jun Ma +22 more
TL;DR: In this paper, the authors conducted an open-label phase 3 multicentre randomised controlled trial at seven institutions in China, where patients were stratified by treatment center and randomly assigned in blocks of four.
Journal ArticleDOI
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed,Sophie Marguet,Anne W.M. Lee,Wai Tong Ng,Jun Ma,Anthony T.C. Chan,Pei Yu Huang,Guopei Zhu,Daniel T.T. Chua,Yong Chen,Hai Qiang Mai,Dora L.W. Kwong,Shie Lee Cheah,James C. Moon,Yuk Tung,Kwan Hwa Chi,George Fountzilas,Jean Bourhis,Jean Pierre Pignon,Pierre Blanchard +19 more
TL;DR: The addition of AC to CRT achieved the highest survival benefit and consistent improvement for all end points, and the addition of IC toCRT achieve the highest effect on DC.
Journal ArticleDOI
Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China
Yong Chen,Meng Zhong Liu,Shao Bo Liang,Jing Feng Zong,Yan Ping Mao,Ling Long Tang,Ying Guo,Ai Hua Lin,Xiang Fa Zeng,Jun Ma +9 more
TL;DR: This trial demonstrated the significant survival benefits of concurrent chemotherapy plus adjuvant chemotherapy in patients with locoregionally advanced NPC in endemic regions of China.
Journal ArticleDOI
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
Yong Chen,Ying Sun,Shao Bo Liang,Jing Feng Zong,Wen Fei Li,Mo Chen,Lei Chen,Yan Ping Mao,Ling Long Tang,Ying Guo,Ai Hua Lin,Meng Zhong Liu,Jun Ma +12 more
TL;DR: The objective of this study was to evaluate the long‐term survival and late toxicities of concurrent‐adjuvant chemotherapy in patients with stage III through IVB nasopharyngeal carcinoma from endemic regions of China.